Drug
Cdx 622
Cdx 622: highest development phase Phase 1, developed by Celldex Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CDX-622 NCT07330778 | Phase 1 | Mild to Moderate Asthma |
| CDX-622 NCT06650761 | Phase 1 |
Latest
No recent events.
Follow Cdx 622 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.